Prothrombinex-VF

Prothrombinex-VF

prothrombin complex concentrate, human

Manufacturer:

CSL Behring

Distributor:

HKRCBTS
Concise Prescribing Info
Contents
Coagulation factors II, IX & X (human)
Indications/Uses
Treatment & perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex factors eg deficiency caused by treatment w/ vit K antagonists, or in case of overdose, when rapid correction of the deficiency is required. Treatment & prophylaxis of bleeding in patients w/ single or multiple congenital deficiency of factor II, IX or X when purified specific coagulation factor is not available.
Dosage/Direction for Use
Contraindications
Hypersensitivity. Known allergy to heparin or history of heparin-induced thrombocytopenia. Active thrombosis or disseminated intravascular coagulation.
Special Precautions
Management of patients w/ isolated factor V or VII. Monitor for inhibitor development, signs of thrombosis, embolism, disseminated intravascular coagulation (DIC), MI. Consider immunization of patients prior to treatment. Pregnancy & lactation. Childn, neonates. Elderly.
Adverse Reactions
Hypercoagulability, DIC, anaphylactic reaction, thrombosis, pulmonary embolism, rash, inj site reaction.
MIMS Class
Haemostatics
ATC Classification
B02BD01 - coagulation factor IX, II, VII and X in combination ; Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.
Presentation/Packing
Form
Prothrombinex-VF powd for inj 500 IU/20 mL
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in